IPO registrations (S-1, F-1) · Registrants
Molecular Templates, Inc.
- SEC CIK
- 1183765 · filings on EDGAR ↗
- Name on the registration
- THRESHOLD PHARMACEUTICALS INC
- Former names
- THRESHOLD PHARMACEUTICALS INC (2002–2017)
- Registration
- Form S-1, first filed 2004-04-09, last 2005-10-07; 2 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2005-02-04
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 9301 AMBERGLEN BLVD, SUITE 100, Austin, TX 78729
- EIN
- 94-3409596
- EDGAR entity type
- operating
- Insiders and CEO pay
- Molecular Templates, Inc. on the corporate pages
Offering terms
- Proposed price range
- $8.00–$10.00 per share (S-1/A filed 2005-02-03)
- Final price
- $7.00 per share, below the range (424B4 filed 2005-02-04, an initial public offering)
- Shares sold
- 5,333,333
- Gross proceeds
- $37,333,331 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol THLD
- Lead underwriters
- BofA Securities (2,400,000 shares); CIBC World Markets (1,600,000 shares); Lazard; William Blair (533,333 shares); Lazard Frères & Co. LLC (800,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: MOLECULAR TEMPLATES, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Molecular Templates, Inc. Fuzzy (name and state)
- Business registration: Molecular Templates, Inc. Fuzzy (name and state)
- Business registration: Molecular Templates, Inc. Fuzzy (name and state)
- Business registration: MOLECULAR TEMPLATES, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: THRESHOLD PHARMACEUTICALS, INC. EXACT (EIN (EXACT))
- Federal award recipient: MOLECULAR TEMPLATES, INC. Fuzzy (name and state)
- Form D issuer: Molecular Templates, Inc. EXACT (CIK (EXACT))
- SEC filer: Molecular Templates, Inc. EXACT (CIK (EXACT))
- Person page: Bruce C Cozadd Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-04-09 | S-1 | S-1 (registration) | THRESHOLD PHARMACEUTICALS INC | 0001193125-04-059933 ↗ |
| 2004-05-10 | S-1/A | S-1/A (amendment) | THRESHOLD PHARMACEUTICALS INC | 0001193125-04-083841 ↗ |
| 2004-06-08 | S-1/A | S-1/A (amendment) | THRESHOLD PHARMACEUTICALS INC | 0001193125-04-100157 ↗ |
| 2004-12-06 | S-1/A | S-1/A (amendment) | THRESHOLD PHARMACEUTICALS INC | 0001193125-04-208148 ↗ |
| 2004-12-29 | S-1/A | S-1/A (amendment) | THRESHOLD PHARMACEUTICALS INC | 0001193125-04-220346 ↗ |
| 2005-01-11 | S-1/A | S-1/A (amendment) | THRESHOLD PHARMACEUTICALS INC | 0001193125-05-004245 ↗ |
| 2005-01-28 | S-1/A | S-1/A (amendment) | THRESHOLD PHARMACEUTICALS INC | 0001193125-05-013610 ↗ |
| 2005-02-03 | S-1/A | S-1/A (amendment) | THRESHOLD PHARMACEUTICALS INC | 0001193125-05-018777 ↗ |
| 2005-02-04 | 424B4 | 424B4 (final prospectus) | THRESHOLD PHARMACEUTICALS INC | 0001193125-05-019829 ↗ |
| 2005-09-27 | S-1 | S-1 (registration) | THRESHOLD PHARMACEUTICALS INC | 0001193125-05-192380 ↗ |
| 2005-10-03 | S-1/A | S-1/A (amendment) | THRESHOLD PHARMACEUTICALS INC | 0001193125-05-195635 ↗ |
| 2005-10-07 | S-1/A | S-1/A (amendment) | THRESHOLD PHARMACEUTICALS INC | 0001193125-05-198568 ↗ |
| 2005-10-12 | 424B4 | 424B4 (final prospectus) | THRESHOLD PHARMACEUTICALS INC | 0001193125-05-199920 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2005-02-03 | S-1/A | registration statement | $8.00–$10.00 | $9.00 | 5,333,333 | $47,999,997 | Nasdaq THLD | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2005-02-04 | 424B4 | final prospectus | $7.00 | 5,333,333 | $37,333,331 | Nasdaq THLD | 5 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Christoffersen Ralph E | Other | 1 | 2006 | ||
| MORGENTHALER PARTNERS VII LP | TenPercentOwner | 1 | 2006 | ||
| ENRIGHT PATRICK G | Director; TenPercentOwner | 15 | 2006–2020 | ||
| JAEGER WILFRED E | Director; Director,TenPercentOwner | 33 | 2006–2016 | ||
| NICHOLSON BARCLAY | TenPercentOwner | 1 | 2006 | ||
| PEQUOT CAPITAL MANAGEMENT INC | Other | 7 | 2006–2007 | ||
| THREE ARCH ASSOCIATES III LP | TenPercentOwner | 1 | 2006 | ||
| THREE ARCH MANAGEMENT III LLC | TenPercentOwner | 1 | 2006 | ||
| THREE ARCH PARTNERS III LP | TenPercentOwner | 1 | 2006 | ||
| WAN MARK A | TenPercentOwner | 1 | 2006 | ||
| Colowick Alan | Officer | Chief Medical Officer | 3 | 2006 | |
| OSTRACH MICHAEL S | Officer | Chief Operating Officer | 3 | 2006 | |
| SELICK HAROLD E | Director; Director,Officer | Chief Executive Officer | 33 | 2006–2024 | |
| SWEARSON JANET I | Officer | Chief Financial Officer | 1 | 2006 | |
| POWELL MICHAEL | Director | 6 | 2006–2008 | ||
| Davis Cathleen Phillips | Officer | VP, Finance and Controller | 6 | 2006–2007 | |
| TANG CAPITAL MANAGEMENT LLC | TenPercentOwner | 4 | 2006–2008 | ||
| TANG CAPITAL PARTNERS LP | TenPercentOwner | 4 | 2006–2008 | ||
| TANG KEVIN C | TenPercentOwner | 4 | 2006–2008 | ||
| HALTER WILLIAM A | Director | 7 | 2006–2009 | ||
| PARKER GEORGE GC | Director | 16 | 2006–2016 | ||
| COZADD BRUCE C | Director | 13 | 2006–2016 | person page Fuzzy | |
| Brawer Michael | Officer | Interim Chief Medical Officer; Senior Medical Strategist | 2 | 2006–2007 | |
| Kaster Kevin R | Officer | Sr. VP Corporate Development | 2 | 2007 | |
| HOFFMANN DAVE | Director | 20 | 2007–2024 | ||
| Curd John G | Officer | President and CMO | 24 | 2007–2011 | |
| Fernandes Joel A | Officer | Senior Vice President; Sr Director Finance/Controller; VP, Finance and Controller; VP, Finance & Controller | 15 | 2007–2016 | |
| ALTA BIOPHARMA MANAGEMENT III LLC | Other; TenPercentOwner | 2 | 2008–2009 | ||
| ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG | Other; TenPercentOwner | 2 | 2008–2009 | ||
| ALTA BIOPHARMA PARTNERS III LP | Other; TenPercentOwner | 2 | 2008–2009 | ||
| ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC | Other; TenPercentOwner | 2 | 2008–2009 | ||
| CHAMPSI FARAH | Other; TenPercentOwner | 2 | 2008–2009 | ||
| DELEAGE JEAN | Other; TenPercentOwner | 2 | 2008–2009 | ||
| HURWITZ EDWARD | Other; TenPercentOwner | 2 | 2008–2009 | ||
| MARDUEL ALIX | TenPercentOwner | 1 | 2008 | ||
| PENHOET EDWARD | Other; TenPercentOwner | 2 | 2008–2009 | ||
| ANDERSON DAVID L | TenPercentOwner | 10 | 2008–2014 | ||
| BAKER G LEONARD JR | TenPercentOwner | 12 | 2008–2014 | ||
| BIRD JEFFREY W | Director; Director,TenPercentOwner; TenPercentOwner | 27 | 2008–2017 | ||
| CAVANAUGH JAMES H | TenPercentOwner | 2 | 2008–2009 | ||
| COXE TENCH | TenPercentOwner | 13 | 2008–2014 | ||
| GAITHER JAMES C | TenPercentOwner | 17 | 2008–2014 | ||
| HealthCare Partners VIII, LLC | TenPercentOwner | 2 | 2008–2009 | ||
| HealthCare Partners VIII, L.P. | TenPercentOwner | 2 | 2008–2009 | ||
| HealthCare Ventures VIII, L.P. | TenPercentOwner | 2 | 2008–2009 | ||
| LAWLOR AUGUSTINE | TenPercentOwner | 2 | 2008–2009 | ||
| LITTLECHILD JOHN W | TenPercentOwner | 2 | 2008–2009 | ||
| Mirabelli Christopher | TenPercentOwner | 2 | 2008–2009 | ||
| SANDS GREGORY P | TenPercentOwner | 8 | 2008–2011 | ||
| SHEEHAN ANDREW T | TenPercentOwner | 10 | 2008–2014 | ||
| Speiser Michael L | TenPercentOwner | 8 | 2008–2014 | ||
| SUTTER HILL ENTREPRENEURS FUND AI LP | Director,TenPercentOwner; TenPercentOwner | 2 | 2008–2014 | ||
| SUTTER HILL ENTREPRENEURS FUND QP LP | Director,TenPercentOwner; TenPercentOwner | 2 | 2008–2014 | ||
| SUTTER HILL VENTURES | Director,TenPercentOwner; TenPercentOwner | 9 | 2008–2014 | ||
| SWEET DAVID E | TenPercentOwner | 11 | 2008–2014 | ||
| WERNER HAROLD R | TenPercentOwner | 2 | 2008–2009 | ||
| WHITE JAMES N | TenPercentOwner | 10 | 2008–2014 | ||
| YOUNGER WILLIAM H JR | TenPercentOwner | 21 | 2008–2014 | ||
| FHM VI, L.L.C. | TenPercentOwner | 4 | 2009–2012 | ||
| FHM VI, L.P. | TenPercentOwner | 4 | 2009–2012 | ||
| Frazier Healthcare VI, L.P. | TenPercentOwner | 4 | 2009–2012 | ||
| Parkinson David Ross | Director | 7 | 2010–2016 | ||
| Pearce Tillman | Officer | Chief Medical Officer | 8 | 2012–2016 | |
| Dyckerhoff Stefan A | TenPercentOwner | 4 | 2012–2014 | ||
| Pullara Samuel J III | TenPercentOwner | 4 | 2012–2014 | ||
| Davar Nipun | Officer | Vice President | 4 | 2014–2015 | |
| SIMON ROBERT L | Officer | Senior Vice President | 3 | 2014–2015 | |
| Kroll Stewart M. | Officer | Chief Operating Officer; Senior Vice President | 3 | 2015–2016 | |
| Longitude Capital Partners III, LLC | TenPercentOwner | 6 | 2017–2020 | ||
| Longitude Venture Partners III, L.P. | TenPercentOwner | 6 | 2017–2020 | ||
| Tammenoms Bakker Juliet | TenPercentOwner | 6 | 2017–2020 | ||
| Broxson Michael | Director,TenPercentOwner | 1 | 2017 | ||
| CAXTON CORP | Director | 4 | 2017–2019 | ||
| CDK ASSOCIATES, L.L.C. | Director | 4 | 2017–2019 | ||
| Hirsch David | Director; Director,TenPercentOwner | 11 | 2017–2022 | ||
| Kovner Bruce | Director | 4 | 2017–2019 | ||
| Morenstein Scott D | Director | 9 | 2017–2021 | ||
| Cunningham Joe H | TenPercentOwner | 6 | 2017–2022 | ||
| FRENCH DOUGLAS D | TenPercentOwner | 6 | 2017–2022 | ||
| Kim Jason S. | Officer | Chief Financial Officer; See remarks; See Remarks | 13 | 2017–2024 | |
| LALANDE KEVIN M. | Director,TenPercentOwner | 14 | 2017–2024 | ||
| Poma Eric E | Director,Officer; Officer | See remarks; See Remarks | 13 | 2017–2024 | |
| Sante Health Ventures I Annex Fund, LP | TenPercentOwner | 6 | 2017–2022 | ||
| SANTE HEALTH VENTURES I LP | TenPercentOwner | 6 | 2017–2022 | ||
| SHV Management Services, LLC | TenPercentOwner | 6 | 2017–2022 | ||
| SHV Management Services, LP | TenPercentOwner | 6 | 2017–2022 | ||
| Valacer David | Officer | Chief Medical Officer | 1 | 2017 | |
| MILLENNIUM PHARMACEUTICALS INC | TenPercentOwner | 1 | 2017 | ||
| Takeda A/S | TenPercentOwner | 1 | 2017 | ||
| Takeda Europe Holdings B.V. | TenPercentOwner | 1 | 2017 | ||
| Takeda Pharma A/S | TenPercentOwner | 1 | 2017 | ||
| TAKEDA PHARMACEUTICAL CO LTD | TenPercentOwner | 1 | 2017 | ||
| Takeda Pharmaceuticals International AG | TenPercentOwner | 1 | 2017 | ||
| Takeda Pharmaceuticals U.S.A., Inc. | TenPercentOwner | 1 | 2017 | ||
| SHV Annex Services, LP | TenPercentOwner | 5 | 2017–2022 | ||
| Cutler Adam D. | Officer | CFO and Treasurer; See remarks; See Remarks | 6 | 2017–2021 | |
| Lanfear Jonathan | Director | 4 | 2018–2023 | ||
| Waltzman Roger J. | Officer | Chief Medical Officer; See remarks; SVP, Chief Medical Officer | 6 | 2019–2023 | |
| Sanders Corazon (Corsee) D. | Director | 7 | 2019–2024 | ||
| BB BIOTECH AG | TenPercentOwner | 25 | 2020–2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-07-31 | Molecular Templates, Inc. | Biotechnology | $90,738,000 | $19,999,998 | 19 | 1 |
| 2019-11-27 | Molecular Templates, Inc. | Biotechnology | $14,999,994 | $14,999,994 | 1 | 2 |
| 2017-08-15 | Molecular Templates, Inc. | Biotechnology | $20,000,000 | $20,000,000 | 1 | 1 |
| 2017-08-15 | Molecular Templates, Inc. | Biotechnology | $40,000,000 | $40,000,000 | 16 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Molecular Templates, Inc. | TX | State business registries | name and state |
| Business registration | Molecular Templates, Inc. | TX | State business registries | name and state |
| Business registration | Molecular Templates, Inc. | TX | State business registries | name and state |
| Business registration | MOLECULAR TEMPLATES, INC. | TX | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | MOLECULAR TEMPLATES, INC. | TX | State business registries | name and state |
| Federal award recipient | MOLECULAR TEMPLATES, INC. | TX | Federal spending (USAspending) | name and state |
| Form D issuer | Molecular Templates, Inc. | TX | Form D private offerings | CIK (EXACT) |
| Form D issuer | Molecular Templates, Inc. | TX | Form D private offerings | name and state |
| Patent assignee | Molecular Templates, Inc. | TX | Patents (USPTO) | name and state |
| SEC filer | Molecular Templates, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Molecular Templates, Inc. | TX | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | THRESHOLD PHARMACEUTICALS, INC. | EIN (EXACT) | ||
| Person page | Bruce C Cozadd | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.